6 September 2023 false Taxfiler 2024.6 15118326business:PrivateLimitedCompanyLtd2023-09-062025-02-28 151183262023-09-05 151183262023-09-062025-02-28 15118326business:AuditExemptWithAccountantsReport2023-09-062025-02-28 15118326business:FilletedAccounts2023-09-062025-02-28 151183262025-02-28 15118326business:Director12023-09-062025-02-28 15118326business:RegisteredOffice2023-09-062025-02-28 15118326core:WithinOneYear2025-02-28 15118326core:ShareCapitalcore:PreviouslyStatedAmount2025-02-28 15118326core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-02-28 15118326core:PreviouslyStatedAmount2025-02-28 15118326business:SmallEntities2023-09-062025-02-28 15118326countries:EnglandWales2023-09-062025-02-28 iso4217:GBP xbrli:pure
Company Registration No. 15118326 (England and Wales)
Nzmpharm Ltd Filleted Accounts for the period from 6 September 2023 to 28 February 2025
Nzmpharm Ltd Filleted Accounts Contents
Page
- 2 -
Nzmpharm Ltd Company Information for the period from 6 September 2023 to 28 February 2025
Director
Uzma Nazim
Company Number
15118326 (England and Wales)
Registered Office
19 Harrowden Court Leicester LE5 4TL England
Accountants
YP Finance Hawthorne House 17A Hawthorne Drive Leicester Leicestershire LE5 6DL
- 3 -
Nzmpharm Ltd Statement of financial position as at 28 February 2025
2025 
Notes
£ 
Current assets
Debtors
45 
Cash at bank and in hand
31,124 
31,169 
Creditors: amounts falling due within one year
(28,069)
Net current assets
3,100 
Net assets
3,100 
Capital and reserves
Called up share capital
100 
Profit and loss account
3,000 
Shareholders' funds
3,100 
For the period ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 17 April 2025 and were signed on its behalf by
Uzma Nazim Director Company Registration No. 15118326
- 4 -
Nzmpharm Ltd Notes to the Accounts for the period from 6 September 2023 to 28 February 2025
1
Statutory information
Nzmpharm Ltd is a private company, limited by shares, registered in England and Wales, registration number 15118326. The registered office is 19 Harrowden Court, Leicester, LE5 4TL, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
4
Debtors
2025 
£ 
Amounts falling due within one year
Trade debtors
45 
5
Creditors: amounts falling due within one year
2025 
£ 
Taxes and social security
6,712 
Other creditors
20,314 
Accruals
1,043 
28,069 
6
Average number of employees
During the period the average number of employees was 1.
- 5 -